naloxone has been researched along with Pituitary-Diseases* in 2 studies
1 trial(s) available for naloxone and Pituitary-Diseases
Article | Year |
---|---|
Failure of naloxone to alter growth hormone and prolactin levels in acromegalic and in hyperprolactinaemic patients.
We examined the effects of high-dose intravenous naloxone administration in four acromegalic patients (mean serum growth hormone level 72 ng/ml) and in seven hyperprolactinaemic women (mean serum prolactin level 59 ng/ml), in order to assess whether this opiate antagonist would be effective in lowering growth hormone and prolactin levels. No effect was observed. This lack of effect suggests that an opioid pathway is not involved in the maintenance of elevated growth hormone or prolactin secretion in these patients. However, conclusions regarding the possible role of endogenous opioids in regulation of pituitary function in normal individuals cannot be drawn from this study. Topics: Acromegaly; Adult; Clinical Trials as Topic; Female; Growth Hormone; Humans; Middle Aged; Naloxone; Pituitary Diseases; Prolactin | 1979 |
1 other study(ies) available for naloxone and Pituitary-Diseases
Article | Year |
---|---|
The effect of naloxone on the secretion of pituitary hormones in patients with acromegaly, microprolactinomas, Cushing's disease and Nelson's syndrome.
Topics: Cushing Syndrome; Humans; Naloxone; Pituitary Diseases; Pituitary Function Tests; Pituitary Hormones, Anterior | 1986 |